The Effects of Patient Features on Opioid Induced End-Tidal CO2
NCT01371903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278
Last updated 2014-03-24
Summary
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.
Conditions
- Opioid Use During Medical Care
Sponsors & Collaborators
-
Albany Medical College
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-11-30
Countries
- United States
Study Locations
More Related Trials
-
Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department
NCT03257319 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
NCT05856136 ·Status: RECRUITING ·Phase: PHASE4
-
OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
NCT00271973 ·Status: COMPLETED ·Phase: PHASE4
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
NCT02299024 ·Status: COMPLETED ·Phase: NA
-
Measuring Changes in Acute Pain in the Emergency Department Using Patient Reported Scales
NCT01723137 ·Status: COMPLETED
-
Fentanyl Patch Pharmacokinetics in Healthy Adults
NCT02531971 ·Status: COMPLETED ·Phase: PHASE4
-
Oxidative Balance in Opioid Therapy
NCT04227223 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
NCT00226421 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
NCT04218409 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge Discharge
NCT01402375 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl
NCT03894800 ·Status: COMPLETED ·Phase: PHASE4
-
Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers
NCT00730054 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients
NCT01591382 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Feasibility of Patient Controlled Analgesia in the ED
NCT01775371 ·Status: COMPLETED ·Phase: NA
-
First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers
NCT01975753 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
NCT00305110 ·Status: COMPLETED ·Phase: PHASE2
-
PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine
NCT06519045 ·Status: ACTIVE_NOT_RECRUITING
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03176121 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT03439904 ·Status: UNKNOWN ·Phase: NA
-
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261 ·Status: COMPLETED ·Phase: PHASE3